NexgenRx Inc. (NXG.V)
- ACCESSWIRE
NexgenRx Announces 2023 Year End Results With Solid Revenue Growth, Continuing Positive EBITDA
TORONTO, ON / ACCESSWIRE / April 5, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2023, with continued revenue growth to $3,573,751 for the quarter ...
- ACCESSWIRE
NexgenRx Announces Share Issuances Under Consulting Agreement
TORONTO, ON / ACCESSWIRE / March 12, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the issuance of an aggregate of 390,625 common shares at a price of $0.32 in respect of the second and third quarterly equity payments under ...
- ACCESSWIRE
NexgenRx Announces Director Resignation
TORONTO, ON / ACCESSWIRE / December 29, 2023 / NEXGENRX INC. ("NexgenRx" or the "Company") announces the retirement of Dave Bennett from its Board of Directors as he has accepted a senior executive role in the industry and as such will be devoting ...
